In order to probe the targeting ability for generated nanoparticles, we used human liver cancer cell line BEL-7404 (2 × 103 cells/well), in which the EpCAM expression rate as measured by flow cytometry was 51.55%. This evidence concerns the gene EPCAM and liver cancer.